首页> Bone marrow transplantation> FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML.

FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML.

导出 OA

翻译打印收藏纠错

第一作者： Yeohan,Song

第一单位： University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.;Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.

作者： Yeohan,Song ^[1] ; John,Magenau ^[2] ; Yumeng,Li ^[3] ; Thomas,Braun ^[3] ; Lawrence,Chang ^[4] ; Dale,Bixby ^[2] ; David A,Hanauer ^[5] ; Komal A,Chughtai ^[1] ; Erin,Gatza ^[4] ; Daniel,Couriel ^[2] ; Steven,Goldstein ^[2] ; Attaphol,Pawarode ^[2] ; Pavan,Reddy ^[2] ; Mary,Riwes ^[2] ; James,Connelly ^[6] ; Andrew,Harris ^[6] ; Carrie,Kitko ^[6] ; John,Levine ^[6] ; Greg,Yanik ^[6] ; Brian,Parkin ^[2] ; Sung Won,Choi ^[6]

作者单位： University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.;Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA. ^[1] Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.;Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.;Hematological Malignancies and Blood and Marrow Transplantation Program, University of Michigan, Ann Arbor, MI, USA. ^[2] School of Public Health, University of Michigan, Ann Arbor, MI, USA.;Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA. ^[3] Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA. ^[4] Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.;Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.;Bioinformatics Core, University of Michigan, Ann Arbor, MI, USA. ^[5] Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.;Hematological Malignancies and Blood and Marrow Transplantation Program, University of Michigan, Ann Arbor, MI, USA.;Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA. ^[6]